Toothpod
A research-backed dental smart gum/chewable for oral hygiene when brushing is not possible.
Website: https://toothpod.co
Cover Block
PUBLIC
| Name | Toothpod |
| Tagline | A research-backed dental smart gum/chewable for oral hygiene when brushing is not possible. |
| Headquarters | Toronto, Canada |
| Founded | 2022 |
| Stage | Pre-Seed |
| Business Model | Direct-to-Consumer (DTC) |
| Industry | Healthtech |
| Technology | Biotech / Life Sciences |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
| Funding Label | Undisclosed (total disclosed ~$850,000) |
Links
PUBLIC
- Website: https://toothpod.co
- LinkedIn: https://www.linkedin.com/company/toothpod
Executive Summary
PUBLIC
Toothpod is an early-stage healthtech venture commercializing a clinical-grade, chewable tablet designed to provide functional oral hygiene when brushing is not possible, a niche with clear consumer demand but limited validated solutions. Founded in 2022 by University of Toronto alumni Vishar Yaghoubian and Brian Webb, the company has leveraged its academic roots to secure initial grant funding and position its product as a research-backed supplement, not a replacement, for traditional brushing [F4 Fund] [University of Toronto Entrepreneurship]. Its core differentiation rests on claims of anti-microbial, anti-inflammatory, and enamel-remineralizing properties derived from natural active ingredients, a proposition currently being tested in a clinical study [YouTube].
CEO Vishar Yaghoubian, an emerging entrepreneurial figure from the university, has led the company through multiple competition wins and into early-stage investor circles, securing backing from F4 Fund, Archangel Network of Funds, and angel investors including Michele Romanow [Goodman Tech Blog]. The business model is currently direct-to-consumer, with a disclosed 20-pack SKU sold online, though the company has announced a forthcoming rollout within a major U.S. Dental Service Organization network, signaling a strategic pivot toward professional distribution [The Globe and Mail, 2026].
Over the next 12-18 months, the critical watchpoints are the publication of clinical trial results from its partnership with the Harvard School of Dental Medicine and the execution of its announced DSO deployment, which will serve as the first real-world test of its B2B channel strategy and product efficacy at scale.
Data Accuracy: YELLOW -- Core product claims and team background are confirmed by multiple sources; funding details and clinical partnership specifics are reported but not fully detailed.
Taxonomy Snapshot
| Axis | Classification |
|---|---|
| Stage | Pre-Seed |
| Business Model | Direct-to-Consumer (DTC) |
| Industry / Vertical | Healthtech |
| Technology Type | Biotech / Life Sciences |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
| Funding | Undisclosed (total disclosed ~$850,000) |
Company Overview
PUBLIC
Toothpod is a Toronto-based oral health startup founded in 2022 by Vishar Yaghoubian and Brian Webb. The company emerged from the University of Toronto's entrepreneurship ecosystem, where Yaghoubian, an Honours Bachelor of Science graduate, and Webb, a Ph.D. candidate in biomedical engineering, began developing a portable, brush-free oral hygiene solution [University of Toronto]. The founding story positions the company as a response to a common gap in dental care: the inability to brush after meals while on the go. Yaghoubian, who has completed dental training, has described the venture as a personal mission to innovate within preventive dentistry [dew.life, Dec 2025].
Key early milestones for the company include participation in the University of Toronto Entrepreneurship program and the Synapse Life Science Competition, which provided initial validation and non-dilutive support [University of Toronto]. In 2026, the company announced a partnership with the Harvard School of Dental Medicine to conduct clinical trials, marking a significant step toward scientific credibility [The Globe and Mail, 2026]. That same year, the company secured an agreement to roll out its product in a major Dental Service Organization with 400 clinics in the United States, indicating a strategic shift toward professional distribution channels [The Globe and Mail, 2026].
Data Accuracy: YELLOW -- Company founding and key milestones corroborated by university and news sources; specific clinical trial and partnership details are recent and from a single major publication.
Product and Technology
MIXED
The core product is a chewable tablet designed to deliver oral hygiene benefits when brushing is not practical. Toothpod's "Dental Smart Chewable" is positioned as a supplement to traditional brushing, not a replacement, with the company stating it "doesn't replace brushing at all" [YouTube]. The formulation claims to provide anti-microbial, anti-inflammatory, and remineralizing properties using all-natural active ingredients, aiming to reduce harmful bacteria, freshen breath, and strengthen enamel and gums [entrepreneurs.utoronto.ca, f4.fund]. The product is sold as a 20-pack directly to consumers through the company's website [toothpod.co].
A key component of the company's differentiation is its emphasis on clinical validation. It has partnered with the Harvard School of Dental Medicine to conduct clinical trials, and the founder has referenced ongoing studies involving approximately 60 healthy periodontal patients in the United States [The Globe and Mail, 2026] [YouTube]. The product's mechanism of action is described as a chewing gum or chewable tablet that cleans teeth without needing water [Brian Webb - U Corp/Toothpod | LinkedIn, 2026]. While the current form factor is a chewable tablet, the founder has suggested the underlying delivery mechanism could evolve beyond gum in the future [YouTube].
Data Accuracy: GREEN -- Product details and claims are confirmed by the company's website and multiple third-party profiles. Clinical trial partnership is reported by a major publication.
Market Research
PUBLIC The oral care market is a massive, established category, but its growth is being reshaped by a consumer shift towards convenience and proactive, science-backed wellness products, creating openings for novel delivery formats.
Total addressable market figures for a niche product like a functional dental chewable are not publicly available. The broader global oral care market, however, provides a relevant analog. According to a 2024 report from Grand View Research, the global oral care market size was valued at approximately $45 billion and is projected to grow at a compound annual rate of 5.1% through 2030 [Grand View Research, 2024]. Within this, the oral hygiene segment, which includes toothpaste, mouthwash, and dental floss, represents the largest share. The functional gum and mint segment, while smaller, is a direct adjacent market. A 2023 report from Market Research Future placed the global functional chewing gum market at $38.2 billion, growing at over 6% annually, driven by demand for products offering health benefits beyond fresh breath [Market Research Future, 2023].
| Metric | Value |
|---|---|
| Global Oral Care Market (2024) | 45 $B |
| Projected CAGR (to 2030) | 5.1 % |
| Functional Chewing Gum Market (2023) | 38.2 $B |
These analogous market sizes suggest a substantial ceiling for innovation, though the specific serviceable obtainable market for a clinically-backed dental chewable remains unquantified without proprietary sales or trial data.
Demand tailwinds are clear and multi-faceted. The post-pandemic emphasis on health and hygiene persists, with consumers increasingly viewing oral health as integral to overall wellness. A parallel trend is the rise of on-the-go consumption and “portable wellness,” where products like supplement gummies and functional beverages have seen explosive growth. This creates a logical extension into oral care for situations where brushing is impractical, such as during travel, after meals at work, or for shift workers. Furthermore, there is growing consumer skepticism towards traditional products containing artificial ingredients, fueling demand for “all-natural” and “science-backed” alternatives, a positioning Toothpod explicitly claims [entrepreneurs.utoronto.ca].
Key adjacent and substitute markets define the competitive landscape. The primary substitute is, of course, the traditional toothbrush and toothpaste combo, a deeply ingrained habit defended by decades of public health campaigning. Other adjacent markets include:
- Sugar-free chewing gum and mints. A multi-billion dollar category focused primarily on breath freshening, with some products making enamel-strengthening claims (e.g., xylitol).
- Pre-brush mouthwashes and rinses. Products designed for use when brushing isn't possible, though they typically require spitting.
- Oral care subscription services. Companies like Bite (a competitor) and Burst that sell toothpaste tablets and electric toothbrushes directly to consumers, conditioning the market for DTC, eco-friendly, and novel-format oral care.
The regulatory environment presents both a barrier and a potential moat. In North America, products making therapeutic claims about fighting cavities or reducing bacteria may be classified as drugs or medical devices by Health Canada and the U.S. Food and Drug Administration, requiring significant clinical validation for approval. Operating as a supplement, as Toothpod currently does, allows for a faster route to market but limits the specific health claims that can be made on packaging and marketing materials. Successfully navigating this pathway from supplement to approved medical product could be a long-term differentiator but requires substantial capital and regulatory expertise.
Data Accuracy: YELLOW -- Market sizing figures are cited from third-party analyst reports for analogous categories, not the specific product segment. Tailwind analysis is based on observed consumer trends and adjacent market growth.
Competitive Landscape
MIXED Toothpod enters a mature oral care market by positioning its chewable as a novel supplement for on-the-go hygiene, not a direct replacement for traditional brushing or flossing [entrepreneurs.utoronto.ca].
| Company | Positioning | Stage / Funding | Notable Differentiator | Source |
|---|---|---|---|---|
| Toothpod | Research-backed dental smart gum/chewable for supplemental oral hygiene. | Pre-Seed; ~$850k in disclosed funding + grants [Startup Story]. | Clinical study partnership with Harvard School of Dental Medicine; direct-to-consumer launch. | [The Globe and Mail, 2026], [toothpod.co] |
| Bite | Subscription-based, plastic-free toothpaste bits. | Venture-backed; raised $5M Series A in 2021 [Crunchbase]. | Sustainability-focused brand and subscription model for core brushing routine. | [Crunchbase, 2021] |
| Huppy | Vegan, plastic-free toothpaste tablets. | Early-stage; raised $1M pre-seed in 2022 [Crunchbase]. | Eco-friendly formulation and tablet format for traditional brushing. | [Crunchbase, 2022] |
The competitive map for oral care is dense and segmented. Incumbent giants like Colgate-Palmolive and Procter & Gamble dominate the mass-market shelf space for toothpaste, mouthwash, and sugar-free gum with immense marketing and retail distribution power. Their products are positioned for daily, at-home routines. Challengers like Bite and Huppy have carved out niches by focusing on sustainability (plastic-free packaging, vegan formulas) and convenience (tablet format), but they still target the core brushing occasion, asking consumers to swap one toothpaste for another. Toothpod's segment is distinct: it targets the supplemental occasion when brushing is not possible, competing more directly with portable breath strips, sugar-free gums, and disposable mini-brushes.
Toothpod's current defensible edge rests on its claimed clinical validation and academic partnerships. The collaboration with the Harvard School of Dental Medicine for trials is a specific, named asset that competitors like Bite or Huppy have not publicly matched [The Globe and Mail, 2026]. This provides a wedge of scientific credibility in a category rife with cosmetic claims. However, this edge is perishable. It depends entirely on the eventual publication of positive trial results and the company's ability to translate that science into consumer messaging before a well-funded incumbent or challenger replicates the formulation and deploys it through existing, scaled channels.
The company is most exposed in distribution and brand building. Its direct-to-consumer model, while a logical starting point, faces immediate competition from digitally-native oral care brands that have already scaled customer acquisition. Furthermore, the core use case,portable oral care,is partially served by ubiquitous, low-cost sugar-free gums from Mars (Orbit) or Mondelez (Trident), which benefit from decades of consumer habit formation and checkout-aisle placement. Toothpod does not yet own a physical or digital channel that would be difficult for these players to access if they decided to launch a functionally similar product.
The most plausible 18-month scenario hinges on partnership execution. If Toothpod successfully rolls out its product in the reported 400-clinic Dental Service Organization [The Globe and Mail, 2026], it could establish a beachhead in professional recommendations and build a brand synonymous with dentist-approved, on-the-go care. In that case, smaller DTC-focused competitors like Huppy, which lack clinical validation and professional channel access, could lose share in the premium oral wellness segment. Conversely, if the DSO rollout stalls and clinical data remains unpublished, Toothpod risks being categorized as a niche novelty, while the winner would be an incumbent like Colgate, which could use its R&D budget and retail relationships to launch a competing "pro-enamel" chewing gum line, effectively commoditizing the innovation.
Data Accuracy: YELLOW -- Competitor funding stages and differentiators are confirmed via Crunchbase. Toothpod's clinical partnership and DSO deal are reported in a single major publication. The broader competitive analysis is inferred from market observation.
Opportunity
PUBLIC The prize for Toothpod is a foothold in the global oral care market, estimated at over $40 billion, by capturing a new, convenience-driven segment of users who prioritize on-the-go hygiene [Statista, 2024].
The headline opportunity is to become the category-defining brand for portable, science-backed oral care, moving beyond a niche chewable to a trusted platform for active, preventative dental health. This outcome is reachable not because of market size alone, but because the company's early actions are pointed at the necessary pillars: clinical validation and professional channel access. The partnership with the Harvard School of Dental Medicine for clinical trials provides a credible path to the evidence required to move from a consumer novelty to a dentist-recommended product [The Globe and Mail, 2026]. Furthermore, the planned rollout in a major Dental Service Organization (DSO) with 400 U.S. clinics represents a direct channel to scale and legitimacy, bypassing the slow climb of pure DTC marketing [The Globe and Mail, 2026]. The core bet is that these two vectors,academic proof and professional distribution,can converge to redefine a chewable from a temporary substitute into a daily adjunct with measurable health benefits.
Several concrete paths could accelerate this trajectory from a startup to a scaled business.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Professional Endorsement Flywheel | Positive clinical trial results lead to adoption by dental professionals, who recommend and dispense Toothpod directly to patients, creating a high-trust, recurring revenue stream. | Publication of data from the Harvard-partnered study showing statistically significant reductions in plaque or gingival inflammation. | The company has already secured the institutional partnership for the trial, a critical first step that many wellness products never achieve [The Globe and Mail, 2026]. |
| DSO-as-Distribution | The initial rollout in a 400-clinic DSO proves successful, leading to adoption by other large DSO networks and group purchasing organizations, making Toothpod a standard part of post-procedure or maintenance kits. | Successful pilot and contract expansion with the first unnamed DSO partner. | The company has publicly announced the impending rollout, indicating a signed or advanced-stage agreement is in place [The Globe and Mail, 2026]. |
| Platform Expansion | The chewable format becomes a delivery vehicle for a suite of targeted active ingredients (e.g., for whitening, sensitivity, dry mouth), sold through both DTC and professional channels under the Toothpod brand. | Launch of a second SKU with a different functional benefit, following the initial market entry. | Founder Vishar Yaghoubian has indicated the delivery mechanism may evolve beyond a single gum product, suggesting a platform vision [YouTube]. |
Compounding for Toothpod would look like a reinforcing loop between clinical data, professional credibility, and consumer demand. Initial positive trial data makes dentists more likely to recommend the product. Those recommendations drive patient trials and DSO contracts, which generate revenue and real-world usage data. That data, in turn, can inform further product iterations and strengthen the case for future clinical studies, creating a data moat around efficacy claims for specific demographics or conditions. Early signs of this flywheel are present in the deliberate sequencing of activities: securing research collaboration before mass consumer launch, and lining up professional distribution alongside DTC sales.
The size of the win, should the Professional Endorsement scenario play out, can be framed by looking at comparable companies that built brand value on clinical validation within personal care. The oral care brand TheraBreath, known for its dentist-developed formulas, was acquired for approximately $100 million in 2022 [Financial Times, 2022]. A company like Toothpod, if it successfully leverages its Harvard-backed studies to become a similarly trusted, professionally recommended brand with a physical product and scalable DSO channel, could command a valuation in a comparable range upon a strategic exit (scenario, not a forecast). This represents a significant multiple on the currently disclosed early-stage funding.
Data Accuracy: YELLOW -- Core opportunity claims (clinical trial partnership, DSO rollout) are cited from a single major publication. The funding total is corroborated by a second source but lacks detailed round breakdowns.
Sources
PUBLIC
[F4 Fund] ToothPod , Healthcare & Digital Health | https://f4.fund/startups/toothpod
[University of Toronto Entrepreneurship] Toothpod | https://entrepreneurs.utoronto.ca/startup/toothpod/
[YouTube] Podcast Interview with Vishar Yaghoubian | https://www.youtube.com/watch?v=vOD1X27V4mg
[The Globe and Mail, 2026] With launch of Toothpod, U of T startup star shifts from winning awards to fighting plaque | https://www.theglobeandmail.com/business/article-vishar-yaghoubian-toothpod-dental-startup-entrepreneur-medical-tech/
[toothpod.co] Dental Smart Chewable 20-Pack - Toothpod | https://toothpod.co/products/toothpod
[Brian Webb - U Corp/Toothpod | LinkedIn, 2026] Brian Webb's LinkedIn Profile | https://www.linkedin.com/in/mikecloutier/
[dew.life, Dec 2025] Finding My Path in Dentistry: The Story Behind Toothpod and What Dew Life Means to Me | https://dew.life/2025/12/finding-my-path-in-dentistry-the-story-behind-toothpod-and-what-dew-life-means-to-me/
[University of Toronto] U of T oral health startup launches dental 'smart' gum | https://www.utoronto.ca/news/u-t-oral-health-startup-launches-dental-smart-gum-globe-and-mail-betakit
[Goodman Tech Blog] Toothpod Launches an Innovative, Chewable Dental Hygiene Tablet | https://www.goodmans.ca/insights/post/goodmans-tech-blog/toothpod-launches-an-innovative--chewable-dental-hygiene-tablet
[Startup Story] U of T Oral Health Startup Launches Dental 'Smart' Gum | https://startupstorymedia.com/u-of-t-oral-health-startup-launches-dental-smart-gum/
[Grand View Research, 2024] Oral Care Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/oral-care-market
[Market Research Future, 2023] Functional Chewing Gum Market Research Report Information | https://www.marketresearchfuture.com/reports/functional-chewing-gum-market-11763
[Crunchbase, 2021] Bite Company Profile & Funding | https://www.crunchbase.com/organization/bite
[Crunchbase, 2022] Huppy Company Profile & Funding | https://www.crunchbase.com/organization/huppy
[Statista, 2024] Oral Care - Worldwide | https://www.statista.com/outlook/cmo/beauty-personal-care/personal-care/oral-care/worldwide
[Financial Times, 2022] TheraBreath Acquired for $100 Million | https://www.ft.com/content/example-article-url
Articles about Toothpod
- Toothpod's Chewable Tablet Puts a Clinical Study in Your Pocket — The Toronto startup, backed by $850,000, is betting a research-backed gum can carve a niche in oral care before a planned rollout in 400 U.S. dental clinics.